GFP
AGN

Gryphon Financial Partners’s Allergan plc AGN Stock Holding History

Gryphon Financial Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-232
Closed -$34K – 175
2019
Q1 		$34K Buy
+232
New +$33.6K 0.01% 126
2018
Q3 		– Sell
-206
Closed -$35K – 923
2018
Q2 		$35K Sell
206
-6
-3% -$963 0.02% 287
2018
Q1 		$36K Buy
212
+28
+15% +$4.7K 0.02% 279
2017
Q4 		$30K Buy
+184
New +$33K 0.02% 338

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gryphon Financial Partners's AGN Position: Q2 2019 in Review

Gryphon Financial Partners sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 232 shares — an estimated $34K sold.

Gryphon Financial Partners first reported a position in AGN in Q4 2017 and held it in 4 quarters. The position peaked at $36K in Q1 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Gryphon Financial Partners reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Gryphon Financial Partners sold 232 Allergan plc shares in Q2 2019, an estimated $34K.
  • Gryphon Financial Partners first reported a position in Allergan plc in Q4 2017 and held it in 4 quarters.
  • Gryphon Financial Partners's Allergan plc position peaked at $36K in Q1 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Gryphon Financial Partners's 13F filing for Q2 2019, filed 9 Aug 2019.